These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10089050)

  • 1. Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy.
    Kato T; Mizokami M; Orito E; Ohba K; Nakano T; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Yasuda K; Iino S
    J Med Virol; 1999 Apr; 57(4):376-82. PubMed ID: 10089050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy.
    Fujisawa T; Horiike N; Michitaka K; Onji M
    J Gastroenterol Hepatol; 2000 Jun; 15(6):632-9. PubMed ID: 10921417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
    Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
    J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
    Kobayashi M; Watanabe K; Ishigami M; Murase K; Ito H; Ukai K; Yano M; Takagi K; Hattori M; Kakumu S; Yoshioka K
    Am J Gastroenterol; 2002 Apr; 97(4):988-98. PubMed ID: 12003437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the co-infection.
    Nagayama R; Miyake K; Okamoto H
    J Med Virol; 1997 Jun; 52(2):156-60. PubMed ID: 9179761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
    Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
    J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.
    Chung RT; Monto A; Dienstag JL; Kaplan LM
    J Med Virol; 1999 Aug; 58(4):353-8. PubMed ID: 10421401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load.
    Ukai K; Ishigami M; Yoshioka K; Kawabe N; Katano Y; Hayashi K; Honda T; Yano M; Goto H
    World J Gastroenterol; 2006 Jun; 12(23):3722-8. PubMed ID: 16773689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
    Murphy MD; Rosen HR; Marousek GI; Chou S
    Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NS5a gene of hepatitis C virus in patients treated with interferon-alpha.
    McKechnie VM; Mills PR; McCruden EA
    J Med Virol; 2000 Apr; 60(4):367-78. PubMed ID: 10686018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.
    Halfon P; Halimi G; Bourlière M; Ouzan D; Durant J; Khiri H; Mercier L; Gerolami V; Cartouzou G
    Liver; 2000 Oct; 20(5):381-6. PubMed ID: 11092256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of serum GBV-C RNA levels under administration of interferon and cyclosporine for patients with GBV infected hepatitis].
    Fujikawa H; Miyakawa H; Nagai K; Kako M
    Nihon Rinsho; 1997 Mar; 55(3):591-6. PubMed ID: 9086764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.
    Lau JY; Qian K; Detmer J; Collins ML; Orito E; Kolberg JA; Urdea MS; Mizokami M; Davis GL
    J Infect Dis; 1997 Aug; 176(2):421-6. PubMed ID: 9237707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon.
    Fukuda M; Chayama K; Tsubota A; Kobayashi M; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
    J Gastroenterol Hepatol; 1998 Apr; 13(4):412-8. PubMed ID: 9641307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy.
    Akuta N; Suzuki F; Tsubota A; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2003 Mar; 69(3):376-83. PubMed ID: 12526048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.
    Sáiz JC; López-Labrador FX; Ampurdanés S; Dopazo J; Forns X; Sánchez-Tapias JM; Rodés J
    J Infect Dis; 1998 Apr; 177(4):839-47. PubMed ID: 9534954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
    Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
    J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.